产品标题 产品货号 产品规格 厂家
Human Ovary: left; Adenocarcinoma of ovary, endometrioid, metastatic from ORIGENE TECHNOLOGIESCS5511425x5umORIGENE TECHNOLOGIES
Human Ovary: left; Adenocarcinoma of ovary, endometrioid, squamous features from ORIGENE TECHNOLOGIESCS5428115x5umORIGENE TECHNOLOGIES
Human Ovary: left; Adenocarcinoma of ovary, mucinous from ORIGENE TECHNOLOGIESCS7030515x5umORIGENE TECHNOLOGIES
Human Ovary: left; Adenocarcinoma of ovary, metastatic from ORIGENE TECHNOLOGIESCS5201245x5umORIGENE TECHNOLOGIES
Human Ovary: left; Adenocarcinoma of ovary, mucinous from ORIGENE TECHNOLOGIESCS6024315x5umORIGENE TECHNOLOGIES
Human Ovary: left; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCS8103105x5umORIGENE TECHNOLOGIES
Human Ovary: left; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCS8151105x5umORIGENE TECHNOLOGIES
Human Ovary: left; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCS5133315x5umORIGENE TECHNOLOGIES
Human Ovary: left; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCS5300205x5umORIGENE TECHNOLOGIES
Human Ovary: left; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCS5178795x5umORIGENE TECHNOLOGIES
Cytochrome P450, family 1, subfamily A, polypeptide 1 (CYP1A1) from ORIGENE TECHNOLOGIESLY400170100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 1, subfamily A, polypeptide 2 (CYP1A2) from ORIGENE TECHNOLOGIESLY424529100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 17, subfamily A, polypeptide 1 (CYP17A1) from ORIGENE TECHNOLOGIESLY400030100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 2, subfamily A, polypeptide 6 (CYP2A6) from ORIGENE TECHNOLOGIESLY424530100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 3, subfamily A, polypeptide 5 (CYP3A5) from ORIGENE TECHNOLOGIESLY400265100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 3, subfamily A, polypeptide 4 (CYP3A4) from ORIGENE TECHNOLOGIESLY413764100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 3, subfamily A, polypeptide 7 (CYP3A7) from ORIGENE TECHNOLOGIESLY424532100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 39, subfamily A, polypeptide 1 (CYP39A1) from ORIGENE TECHNOLOGIESLY413838100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 4, subfamily A, polypeptide 22 (CYP4A22) from ORIGENE TECHNOLOGIESLY423245100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 27, subfamily A, polypeptide 1 (CYP27A1), nuclear gene encoding mitochondrial protein from ORIGENE TECHNOLOGIESLY400268100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 7, subfamily A, polypeptide 1 (CYP7A1) from ORIGENE TECHNOLOGIESLY424522100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 11, subfamily A, polypeptide 1 (CYP11A1), nuclear gene encoding mitochondrial protein, transcript variant 1 from ORIGENE TECHNOLOGIESLY424523100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 20, subfamily A, polypeptide 1 (CYP20A1) from ORIGENE TECHNOLOGIESLY403595100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 2, subfamily C, polypeptide 18 (CYP2C18), transcript variant 1 from ORIGENE TECHNOLOGIESLY424527100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 2, subfamily D, polypeptide 6 (CYP2D6), transcript variant 1 from ORIGENE TECHNOLOGIESLY424985100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 2, subfamily D, polypeptide 6 (CYP2D6), transcript variant 2 from ORIGENE TECHNOLOGIESLY422597100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 2, subfamily E, polypeptide 1 (CYP2E1) from ORIGENE TECHNOLOGIESLY400264100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 2, subfamily D, polypeptide 6 (CYP2D6), transcript variant 1 from ORIGENE TECHNOLOGIESLY424921100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 4, subfamily F, polypeptide 12 (CYP4F12) from ORIGENE TECHNOLOGIESLY402967100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 4, subfamily F, polypeptide 22 (CYP4F22) from ORIGENE TECHNOLOGIESLY406600100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 4, subfamily F, polypeptide 8 (CYP4F8) from ORIGENE TECHNOLOGIESLY416092100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 4, subfamily F, polypeptide 11 (CYP4F11), transcript variant 2 from ORIGENE TECHNOLOGIESLY427033100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 4, subfamily F, polypeptide 11 (CYP4F11), transcript variant 1 from ORIGENE TECHNOLOGIESLY412026100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 2, subfamily J, polypeptide 2 (CYP2J2) from ORIGENE TECHNOLOGIESLY424525100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 2, subfamily R, polypeptide 1 (CYP2R1) from ORIGENE TECHNOLOGIESLY411259100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 2, subfamily S, polypeptide 1 (CYP2S1) from ORIGENE TECHNOLOGIESLY410796100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 4, subfamily X, polypeptide 1 (CYP4X1) from ORIGENE TECHNOLOGIESLY406024100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 4, subfamily Z, polypeptide 1 (CYP4Z1) from ORIGENE TECHNOLOGIESLY405940100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 2, subfamily W, polypeptide 1 (CYP2W1) from ORIGENE TECHNOLOGIESLY413554100 ugORIGENE TECHNOLOGIES
Mouse programmed cell death 1 (PD-1 / PDCD1) from ORIGENE TECHNOLOGIESTP70025820 ugORIGENE TECHNOLOGIES
Mouse programmed cell death 1 (PD-1 / PDCD1) from ORIGENE TECHNOLOGIESTP70025720 ugORIGENE TECHNOLOGIES
Human Breast, left; Carcinoma in situ of breast from ORIGENE TECHNOLOGIESCS7151715x5umORIGENE TECHNOLOGIES
Human Breast, left; Carcinoma in situ of breast from ORIGENE TECHNOLOGIESCS6122745x5umORIGENE TECHNOLOGIES
Human Breast, left; Carcinoma in situ of breast, ductal from ORIGENE TECHNOLOGIESCS7145575x5umORIGENE TECHNOLOGIES
Human Breast, left; Carcinoma in situ of breast from ORIGENE TECHNOLOGIESCS5508945x5umORIGENE TECHNOLOGIES
Human Breast, left; Carcinoma in situ of breast, ductal from ORIGENE TECHNOLOGIESCS8140215x5umORIGENE TECHNOLOGIES
Human Breast, left; Carcinoma in situ of breast, ductal from ORIGENE TECHNOLOGIESCS5488845x5umORIGENE TECHNOLOGIES
Human Breast, left; Carcinoma in situ of breast, ductal from ORIGENE TECHNOLOGIESCS5526675x5umORIGENE TECHNOLOGIES
Human Breast, left; Carcinoma in situ of breast, ductal from ORIGENE TECHNOLOGIESCS5489015x5umORIGENE TECHNOLOGIES
Human Breast, left; Carcinoma in situ of breast, ductal from ORIGENE TECHNOLOGIESCS6505825x5umORIGENE TECHNOLOGIES
 |< < 5149 5150 5151 5152 5153 5154 5155 5156 5157 > >| 第 5152/6274 页